跳至主要内容
临床试验/EUCTR2009-017387-16-FR
EUCTR2009-017387-16-FR进行中(未招募)1 期

To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapy

ovo Nordisk Pharmaceutique S.A.S0 个研究点目标入组 0 人开始时间: 2010年2月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Only children whom Norditropin® treatment is indicated in accordance with labelling will be included in this study
  • Children receiving growth hormone therapy for at least one year
  • Age = 6 years
  • written informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Contraindications to Norditropin® growth hormone therapy as stated in the summary of product characteristics.
  • Patients who have previously been enrolled in this study.
  • The receipt of any investigational medicinal product within 3 months prior to this trial.
  • Suffer from a life threatening disease

研究者

发起方
ovo Nordisk Pharmaceutique S.A.S

相似试验